To determine if the identified P-gp and BCRP inhibitor derivative 16 is able to re-sensitize resistant cancer cells to chemotherapy, P-gp expressing HCT-15 cells and BCRP-expressing MCF-7/MX cells were co-treated with doxorubicin or mitoxantrone and different concentrations of compound 16. This evidence concerns the gene PGP and cancer.